Healthcare

Global Alzheimer's Drugs Market 2014-2018

  • TEC17978
  • 108 Pages
  • June 2014
  • Healthcare
About Alzheimers Disease
Alzheimer's disease is a progressive, irreversible degeneration of the brain that disrupts the thinking, language, behavioral and cognitive skills of a person. AD is more prevalent in people aged 65 years or above and affects women more than men. Globally, 35 million people are suffering from AD and this number is expected to double by 2030. AD arises due to the failure of synaptic transmission, which results in eventual death of the neurons present in the brain. AD is characterized by the accumulation of beta-amyloid plaques outside and around the neurons and the formation of neurofibrillary tangles inside the nerve cells. Neuronal loss associated with AD leads to a reduction in brain size and deposition of debris from dead and dying neurons inside the brain. AD can be categorized into Early-onset AD, Late-onset AD, and Familial AD. Early-onset AD is a rare form of AD that affects people younger than 65 years of age. Late-onset AD is the most prevalent form of AD and usually affects people aged 65 years or above. Familial AD is the inheritable form of AD with least prevalence among the three.
TechNavio's analysts forecast the Global Alzheimers Disease Drugs market will grow at a CAGR of 2.61 percent over the period 2014-2018.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Alzheimer's Disease Drugs market for the period 2014-2018. To calculate the market size, the report considers revenue generated through the sales of various drugs administered to treat dementia associated with Alzheimer's disease.
The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the Global Alzheimer's Disease Drugs market. In addition, it discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.
TechNavio's report, the Global Alzheimers Disease Drugs Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Alzheimers Disease Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
Americas
EMEA
APAC
Key Vendors
Eisai Co., Ltd.
Forest Laboratories Inc.
Janssen Pharmaceuticals Inc.
Novartis AG
Other Prominent Vendors
Adamas Pharmaceuticals Inc.
Archer Pharmaceuticals Inc.
Eli Lilly and Co.
F. Hoffmann-La Roche Ltd.
FORUM Pharmaceuticals Inc.
H. Lundbeck A/S
Merck & Co., Inc.
MorphoSys AG
Otsuka Pharmaceutical Development & Commercialization Inc./ Otsuka America Pharmaceutical, Inc.
Takeda Pharmaceutical Co., Ltd.
TauRx Pharmaceuticals Ltd.
Zinfandel Pharmaceuticals Inc.
Key Market Driver
Increasing Aging Population
For a full, detailed list, view our report
Key Market Challenge
Poor Diagnosis of Alzheimers Disease
For a full, detailed list, view our report
Key Market Trend
Increasing Incidence, Prevalence, and Mortality of Alzheimers Disease
For a full, detailed list, view our report
Key Questions Answered in this Report
What will the market size be in 2018 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.
Please Select Format

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

World Prepacked Column Market - Opportunities and Forecast, 2014 - 2020

Prepacked columns are ready-to-use columns for chromatography testing, which are standardized high-performance bioprocessing columns prepacked with a range of bioprocess media. It is used in several chromatographic applications, such as ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Asia Pacific Spine Surgery Devices Market - Opportunities and Forecasts, 2015 - 2020

Spine surgery devices are used in surgeries performed for treatment of spinal cord disorders, trauma, bleeding, tumors and others. These devices are used for the treatment of spinal disorders, such ...

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850

Read More >>

Global Arthroscopic Devices Market - Opportunities and Forecast, 2015 - 2020

Arthroscopic devices are the devices used for diagnosing and treating joint problems concerning shoulders, knee, hips, elbow, and others. When X-ray and other imaging studies fails to give a clear ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

World Chiral Separation Column Market - Opportunities and Forecasts, 2015 - 2020

Chiral separation column is a technique in which two enantiomers of the same compound with different affinity are separated. The chiral separation is significant, because most of the bioorganic molecules ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Heart Blocks Treatment Market (Type of Heart Block, Mode of Treatment, Location of Treatment, and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation, and Forecast, 2014 - 2021

Heart block is the disease of cardiovascular electrical system, which controls the rhythm and rate of the heart. Heart block mainly occurs due to disturbed and slowed electrical signals across ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Americas Clinical Chemistry Analyzer Market - Opportunities and Forecasts, 2014 - 2019

A clinical chemistry analyzer is used to determine concentration of metabolites, proteins, sugars, and electrolytes in samples of bodily fluids, such as plasma, serum, urine, and others. It is a ...

July 2017  |   Price:$ 3390    | Pre Book Price:$ 3390

Read More >>

2017 © Copyright Big Market Research

View Pricing >>